With the rapidly increasing use of immunotherapy in the treatment of some cancers, oncology nurses need to be comfortable and knowledgeable in administering immunotherapeutic treatments and assessing patients for immune-related adverse events. In this interview with i3 Health, Keri Mahoney, JD, RN, CPHRM, discusses her immunotherapy educational intervention for nurses, which she presented in a poster at the Oncology Nursing Society (ONS) 44th Annual Congress in Anaheim, California. What was the ...
Chimeric antigen receptor (CAR) T-cell therapy is a new form of immunotherapy in which a patient's own T cells are collected and genetically altered to target cancer cells. Although CAR T-cell therapy has shown encouraging clinical trial results in patients with acute lymphoblastic leukemia and B-cell lymphomas, they are associated with severe adverse events such as cytokine release syndrome, neurotoxicity, tumor lysis syndrome, and graft-versus-host disease. Many of the patients who receive CAR...
Patient education regarding the purpose and side effects of medications can be important to ensuring adherence and optimizing patient outcomes. However, it can be difficult for patients to absorb this information while experiencing an episode of acute illness, especially given the anxiety that can accompany a frightening diagnosis such as cancer. Margaret Highley, MSN, RN, OCN®, and members of the surgical oncology unit at The James Cancer Hospital and Solove Research Institute at The Ohio State...
Lung cancer screening using low-dose computed tomography (CT) has been endorsed by the United States Preventive Services Task Force and is covered by most insurances, yet this service is still underutilized, and some individuals at high risk for lung cancer may not know that it exists. Aimee Strong, MSN, AGACNP-BC, investigated whether social media could be used to educate high-risk individuals about lung cancer screening and motivate them to discuss screening with their health care providers. ...
In order to accurately recognize the continuing medical education (CME) needs and preferences of urology/oncology health care providers, i3 Health administered a survey to participants at the 66th Society of Government Service Urologists Kimbrough Urological Seminar. The results obtained from the survey will be used by i3 Health in the planning and implementation of CME-approved activities. Of the 22 participants who completed the survey, 72.7% were urologists, 18.2% were residents, 4.5% were fe...